Spots Global Cancer Trial Database for Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours
Official Title: A Phase I, Open-Label, Multi-Center, Dose-Escalation Study to Assess the Safety and Tolerability, and Pharmacokinetics of AZD1480 Administered as Daily Oral Monotherapy in Patients With Advanced Solid Malignancies in the Escalation Phase and EGFR or ROS Mutant NSCLC or Non-Smokers With Lung Metastasis in the Expansion Phase.
Study ID: NCT01112397
Conditions
Interventions
Study Description
Brief Summary: This study is being conducted to assess the safety, tolerability and PK of AZD1480 in patients with advanced solid malignancies.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Aurora, Colorado, United States
Research Site, Detroit, Michigan, United States
Research Site, Philadelphia, Pennsylvania, United States
Contact Details
Name: Gregory Curt, MD
Affiliation: AstraZeneca
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
